Medifron DBT Co., Ltd. announces private placement of 41,420,118 shares at an issue price of KRW 1,014 for a gross proceeds of KRW 41,999,999,652 on February 15, 2024. The transaction is expected to close on April 30, 2024. The transaction has been approved by the board of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,463 KRW | +1.39% | -3.18% | +48.83% |
1st Jan change | Capi. | |
---|---|---|
+48.83% | 9.11Cr | |
+91.22% | 10TCr | |
+3.22% | 3.04TCr | |
+5.33% | 2.33TCr | |
+15.17% | 2.06TCr | |
-6.41% | 1.65TCr | |
+3.49% | 1.39TCr | |
+5.41% | 1.19TCr | |
+16.95% | 1.07TCr | |
+13.59% | 999.77Cr |
- Stock Market
- Equities
- A065650 Stock
- News Hyper Corporation Inc.
- Medifron DBT Co., Ltd. announced that it expects to receive KRW 41.999999652 billion in funding